Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-16-058648

Chief Executive Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Suzdak Peter David · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-03-18 Grant or award : show line 1 in the form +60,000 $0.32 $19,386 60,000 D
Loading xslF345X03/doc1.xml…